Cresco Labs (OTCMKTS:CRLBF) Shares Down 0.6% - Time to Sell?

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report)'s stock price traded down 0.6% on Monday . The company traded as low as $0.86 and last traded at $0.89. 313,011 shares were traded during trading, a decline of 42% from the average session volume of 539,036 shares. The stock had previously closed at $0.89.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CRLBF. Roth Capital raised shares of Cresco Labs to a "strong-buy" rating in a research note on Sunday, November 10th. Cormark cut Cresco Labs from a "moderate buy" rating to a "hold" rating in a report on Monday, November 11th. Finally, Atb Cap Markets lowered shares of Cresco Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 9th. Four investment analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Cresco Labs has an average rating of "Moderate Buy" and a consensus target price of $2.50.

Cresco Labs Trading Up 3.6 %

The firm has a market cap of $429.47 million, a P/E ratio of -4.40 and a beta of 1.79. The firm has a fifty day simple moving average of $0.91 and a 200-day simple moving average of $1.28. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Remove Ads